Explore evidence

10.2 %The identified predictors accounted for 10.2% of the explained variability in HIV-related stigma among adults living with HIV from Kilifi.

KenyaHIV-related stigmapublished 2022BMJ openPubMeddocument of 4 observations

44,780 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2022 was 44,780.

KenyaVIH/sidaobserved FY 2022published 2025The Pediatric infectious disease journalPubMeddocument of 10 observations

79 %79% (n = 379) of the initial cohort (n = 480) were on zidovudine/abacavir + lamivudine + efavirenz/nevirapine for a median duration of 2 years.

KenyaVIH/sidaobserved 2010-2013published 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

13 %Among 31 women treated for trichomoniasis, the concentration of vaginal HIV-1 RNA was above the limit for quantitation during infection in 4 women (13%).

Kenyatrichomoniasis · VIH/sidapublished 2011BMC infectious diseaseseurope_pmcdocument of 5 observations

0.5 %The R561H mutation emerged at a low frequency (0.5%) in 2023 in 2 counties.

Kenyapaludismeobserved 2023published 2025Scientific reportsPubMeddocument of 6 observations

100 %Sensitivity among people living with HIV with suspected tuberculosis was 100% versus sputum Xpert alone.

Kenyatuberculose · VIH/sidapublished 2022PloS onePubMeddocument of 10 observations

0.7 %Mortality by 6 months after discharge was 0.7% among children with severe malaria in western Kenya.

Kenyapaludismeobserved 2008 and 2013published 2023The American journal of tropical medicine and hygienePubMeddocument of 7 observations

Clinical results from the OVIVA trial indicate that oral antibiotics are non-inferior to intravenous antibiotics for the treatment of bone and joint infections.

Kenyabone and joint infectionspublished 2019Wellcome open researcheurope_pmcdocument of 4 observations

Within isolates from Western Kenya, the prevalence of biomarkers associated with chloroquine resistance (e.g. Pfcrt K76T) were significantly reduced compared to wider East African populations.

Kenyapaludismepublished 2024Scientific reportsPubMeddocument of 3 observations

64 %Sixty-four percent of female sex workers in Mombasa County, Kenya had tested for HIV within three months.

KenyaVIH/sidapublished 2024The Pan African medical journalPubMeddocument of 6 observations

2.9 AORCaregivers' ability to recognize malaria symptoms was associated with higher odds of seeking timely malaria treatment for their children (adjusted odds ratio = 2.9).

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 5 observations

12.9 %Antiretroviral therapy averted between 12.9% and 39.8% of HIV infections among people who inject drugs in Kenya in 2020 due to suboptimal viral suppression.

KenyaVIH/sidaobserved 2020published 2022AIDS (London, England)PubMeddocument of 8 observations

80 %80% of ovarian cancer cases in Mauritius were of epithelial subtypes.

Kenyaovarian cancerpublished 2024International journal of cancereurope_pmcdocument of 14 observations

6.9 %The mortality of children and adolescents aged 0–18 years managed for diabetic ketoacidosis at Kenyatta National Hospital was 6.9%.

Kenyadiabetic ketoacidosisobserved 2013–2018published 2020Journal of diabetes researchPubMeddocument of 10 observations

18.9 %Submicroscopic Plasmodium parasitaemia prevalence was 18.9% before indoor residual spraying (IRS) in Homa Bay County, Kenya.

Kenyasubmicroscopic Plasmodium parasitaemiaobserved February 2018published 2022Malaria journalPubMeddocument of 8 observations

7.5 %Six-month mortality among HIV-infected patients in Central Kenya was 7.5% in 2004 and reduced to 3.8% in 2014.

KenyaVIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

Less than half of the included patients were alive 3 years after a cancer diagnosis for oral cavity cancer in sub-Saharan Africa.

Kenyaoral cavity cancerpublished 2024The Lancet. Global healtheurope_pmcdocument of 12 observations

90 %Of 1910 female index clients who tested positive for HIV, 1724 (90%) received assisted partner services.

KenyaVIH/sidaobserved May 1, 2018 to March 31, 2020published 2023The Lancet. Global healthPubMeddocument of 11 observations

73 %Lineage B.1 accounted for 73% of sequenced SARS-CoV-2 infections in Coastal Kenya during Wave 1.

KenyaCOVID-19observed Wave 1published 2022eLifeeurope_pmcdocument of 6 observations

98 %The Pfmdr1 N86 variant was identified in 98% of isolates on Ngodhe island, Kenya.

Kenyapaludismeobserved 2015 and 2016published 2023Scientific reportsPubMeddocument of 5 observations

2,370,000,000 inhabitantsIn 2007, 2.37 billion people lived in areas at any risk of Plasmodium falciparum transmission.

Kenyapaludismeobserved 2007published 2008PLoS medicineeurope_pmcdocument of 5 observations

60 %Among 4805 women living with HIV in Kenya, 60% reported receiving family planning counseling during the last year.

KenyaVIH/sidaobserved 2016published 2021ContraceptionPubMeddocument of 2 observations

98 %Yemen contributes to over 98% of the clinical burden of malaria on the Arabian Peninsula.

Kenyapaludismepublished 2013Advances in parasitologyeurope_pmcdocument of 2 observationsDOI 10.1016/b978-0-12-407706-5.00003-4

55 %55% of non-severe test positive malaria patients were treated with artemether.

Kenyapaludismeobserved April 2019published 2020Malaria journaleurope_pmcdocument of 20 observations

9.6 yearsThe mean time from HIV diagnosis to enrollment was 9.6 years (SD 3.9 years) among women living with HIV in Kenya.

KenyaVIH/sidapublished 2021International journal of STD & AIDSPubMeddocument of 5 observations